Índice

• • ·Contents

    Página :A1

    
• • ·Editorial Board

    Página :A5

    
• • ·Information for Readers

    Página :A6

    

• Editorials

  • ·Learning from history: A commentary on the American Heart Association Science Advisory on depression screening

    Página :503-505

    Brett D. Thombs, Lisa R. Jewett, Ruby Knafo, James C. Coyne, Roy C. Ziegelstein

    
  • ·The high cost of nonadherence after percutaneous coronary intervention—Can health care reform solve this problem?

    Página :506-508

    Debabrata Mukherjee

    

• Trial Design

  • ·Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: The CHILLAS study

    Página :509

    Shui-ping Zhao, Dao-quan Peng, Bi-lian Yu, Yong Huo, the CHILLAS investigators c

    Resumen Resumen Esquema Esquema  
  • ·Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib

    Página :513

    Christopher P. Cannon, Hayes M. Dansky, Michael Davidson, Antonio M. Gotto, Eliot A. Brinton, A. Lawrence Gould, Michael Stepanavage, Sherry Xueyu Liu, Sukrut Shah, Joseph Rubino, Patrice Gibbons, Anne Hermanowski-Vosatka, Bruce Binkowitz, Yale Mitchel, Philip Barter, for the DEFINE investigators 1

    Resumen Resumen Esquema Esquema  
  • ·SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease

    Página :520

    Eugenia Nikolsky, Alexandra J. Lansky, Krishnankutty Sudhir, Julie Doostzadeh, Donald E. Cutlip, Robert Piana, Xiaolu Su, Roseann White, Charles A. Simonton, Gregg W. Stone

    Resumen Resumen Esquema Esquema  
  • ·Design and rationale of the TRI-stent Adjudication Study (TRIAS) Program

    Página :527

    Margo Klomp, Marcel A.M. Beijk, Niels J.W. Verouden, Jan G.P. Tijssen, Robbert J. de Winter, on behalf of all TRIAS Investigators a

    Resumen Resumen Esquema Esquema  
  • ·The Family Atherosclerosis Monitoring In earLY life (FAMILY) study : Rationale, design, and baseline data of a study examining the early determinants of atherosclerosis

    Página :533-539

    Katherine M. Morrison, Stephanie A. Atkinson, Salim Yusuf, Jacqueline Bourgeois, Sarah McDonald, Matthew J. McQueen, Richard Persadie, Barry Hunter, Janice Pogue, Koon Teo, the FAMILY investigators

    Resumen Resumen Esquema Esquema  

• Clinical Investigations

  • ·Differential effects of afterload on left ventricular long- and short-axis function: Insights from a clinical model of patients with aortic valve stenosis undergoing aortic valve replacement

    Página :540-545

    Shemy Carasso, Oved Cohen, Diab Mutlak, Zvi Adler, Jonathan Lessick, Shimon A. Reisner, Harry Rakowski, Gil Bolotin, Yoram Agmon

    Resumen Resumen Esquema Esquema  
  • ·Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure

    Página :546-553

    Paul A. Heidenreich, William R. Lewis, Kenneth A. LaBresh, Lee H. Schwamm, Gregg C. Fonarow

    Resumen Resumen Esquema Esquema  
  • ·Cardiovascular events with absent or minimal coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA)

    Página :554-561

    Matthew J. Budoff, Robyn L. McClelland, Khurram Nasir, Philip Greenland, Richard A. Kronmal, George T. Kondos, Steven Shea, Joao A.C. Lima, Roger S. Blumenthal

    Resumen Resumen Esquema Esquema  
  • ·Association of aortic valve calcification to the presence, extent, and composition of coronary artery plaque burden: From the Rule Out Myocardial Infarction using Computer Assisted Tomography (ROMICAT) trial

    Página :562-568

    Amir A. Mahabadi, Fabian Bamberg, Michael Toepker, Christopher L. Schlett, Ian S. Rogers, John T. Nagurney, Thomas J. Brady, Udo Hoffmann, Quynh A. Truong

    Resumen Resumen Esquema Esquema  
  • ·Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER Registry

    Página :569-575

    Tomasz Rakowski, Zbigniew Siudak, Artur Dziewierz, Ralf Birkemeyer, Jacek Legutko, Waldemar Mielecki, Rafal Depukat, Magnus Janzon, Justyna Stefaniak, Krzysztof Zmudka, Jacek S. Dubiel, Lukasz Partyka, Dariusz Dudek

    Resumen Resumen Esquema Esquema  
  • ·Drug-eluting stents: A study of international practice

    Página :576-584

    David Austin, Keith G. Oldroyd, David R. Holmes, Charanjit S. Rihal, P. Diane Galbraith, William A. Ghali, Victor Legrand, Yves Taeymans, Alex McConnachie, Jill P. Pell, on behalf of the APPROACH Investigators, Belgian Working Group on Invasive Cardiology, Mayo Clinic PCI Registry, and Scottish Coronary Revascularisation Registry

    Resumen Resumen Esquema Esquema  
  • ·Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: A comparison of two strategies

    Página :585-591

    Periklis A. Davlouros, Aggelos Arseniou, George Hahalis, John Chiladakis, Andreas Mazarakis, Anastasia Damelou, Marina Karakantza, Fotini Paliogianni, Nikolaos Karogiannis, Dimitrios Alexopoulos

    Resumen Resumen Esquema Esquema  
  • ·Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents

    Página :592

    Dennis T. Ko, Maria Chiu, Helen Guo, Peter C. Austin, Jean-François Marquis, Jack V. Tu

    Resumen Resumen Esquema Esquema  
  • ·Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: Four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial

    Página :e43

    Emilio Di Lorenzo, Rosario Sauro, Attilio Varricchio, Michele Capasso, Tonino Lanzillo, Fiore Manganelli, Ciro Mariello, Francesco Siano, Maria Rosaria Pagliuca, Giovanni Stanco, Giuseppe Rosato, Giuseppe De Luca

    Resumen Resumen Esquema Esquema  
  • ·Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: The Studying the Treatment of Acute hyperTension (STAT) Registry

    Página :599

    Jason N. Katz, Joel M. Gore, Alpesh Amin, Frederick A. Anderson, Joseph F. Dasta, James J. Ferguson, Kurt Kleinschmidt, Stephan A. Mayer, Alan S. Multz, W. Frank Peacock, Eric Peterson, Charles Pollack, Gene Yong Sung, Andrew Shorr, Joseph Varon, Allison Wyman, Leigh A. Emery, Christopher B. Granger, on behalf of the STAT Investigators 1

    Resumen Resumen Esquema Esquema  
  • ·Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis

    Página :607-614

    Lawreen H. Connors, Tatiana Prokaeva, Amareth Lim, Roger Théberge, Rodney H. Falk, Gheorghe Doros, Alan Berg, Catherine E. Costello, Carl O'Hara, David C. Seldin, Martha Skinner

    Resumen Resumen Esquema Esquema  
  • ·Insertion/deletion polymorphism in ?₂-adrenergic receptor gene is a genetic risk factor for sudden cardiac death

    Página :615-621

    Jari A. Laukkanen, Timo H. Mäkikallio, Jussi Kauhanen, Sudhir Kurl

    Resumen Resumen Esquema Esquema  
  • ·Electrocardiographic predictors of atrial fibrillation

    Página :622-628

    Marco V. Perez, Frederick E. Dewey, Rachel Marcus, Euan A. Ashley, Amin A. Al-Ahmad, Paul J. Wang, Victor F. Froelicher

    Resumen Resumen Esquema Esquema  
  • ·Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study

    Página :629-636

    Hiroshi Watanabe, Toru Watanabe, Shigeru Sasaki, Kojiro Nagai, Dan M. Roden, Yoshifusa Aizawa

    Resumen Resumen Esquema Esquema  
  • ·Drug-eluting versus bare-metal stents for treating saphenous vein grafts

    Página :637-643

    Mehdi H. Shishehbor, Riem Hawi, Inder M. Singh, E. Murat Tuzcu, Deepak L. Bhatt, Stephen G. Ellis, Samir R. Kapadia

    Resumen Resumen Esquema Esquema  
  • ·Characteristics and in-hospital outcomes for nonadherent patients with heart failure: Findings from Get With The Guidelines-Heart Failure (GWTG-HF)

    Página :644-652

    Amrut V. Ambardekar, Gregg C. Fonarow, Adrian F. Hernandez, Wenqin Pan, Clyde W. Yancy, Mori J. Krantz, for the Get With the Guidelines Steering Committee and Hospitals

    Resumen Resumen Esquema Esquema  
  • ·Blood transfusion for acute decompensated heart failure—friend or foe?

    Página :653-658

    Moshe Garty, Eytan Cohen, Alexander Zuchenko, Solomon Behar, Valentina Boyko, Zaza Iakobishvili, Moshe Mittelman, Alexander Battler, Avraham Shotan, Shmuel Gottlieb, Avraham Caspi, David Hasdai, for the Heart Failure Survey in ISrael (HFSIS) Investigators

    Resumen Resumen Esquema Esquema  
  • ·Red cell distribution width in heart failure: Prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state

    Página :659-666

    Zsolt Förhécz, Tímea Gombos, Gábor Borgulya, Zoltán Pozsonyi, Zoltán Prohászka, Lívia Jánoskuti

    Resumen Resumen Esquema Esquema  
  • ·Correction

    Página :666

    
  • ·Coffee consumption and risk of heart failure in men: An analysis from the Cohort of Swedish Men

    Página :667-672

    Hanna N. Ahmed, Emily B. Levitan, Alicja Wolk, Murray A. Mittleman

    Resumen Resumen Esquema Esquema  
  • ·Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: Data from The Heart and Soul Study

    Página :673-679

    Bill P.C. Hsieh, Adam M. Rogers, Beeya Na, Alan H.B. Wu, Nelson B. Schiller, Mary A. Whooley

    Resumen Resumen Esquema Esquema  
  • ·Treatment of stable angina pectoris by ivabradine in every day practice: The REDUCTION Study

    Página :e51

    Ralf Köster, Jan Kaehler, Thomas Meinertz, for the REDUCTION Study Group

    Resumen Resumen Esquema Esquema  
  • ·Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery

    Página :680-687

    Jason N. Katz, Amanda L. Stebbins, John H. Alexander, Harmony R. Reynolds, Karen S. Pieper, Witold Ruzyllo, Karl Werdan, Alexander Geppert, Vladimir Dzavik, Frans Van de Werf, Judith S. Hochman, for the TRIUMPH Investigators

    Resumen Resumen Esquema Esquema  
  • ·Characterization and outcomes of women and men with non–ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: Results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) Quality Improvement Initiative

    Página :688-694

    Erika R. Gehrie, Harmony R. Reynolds, Anita Y. Chen, Brian H. Neelon, Matthew T. Roe, W. Brian Gibler, E. Magnus Ohman, L. Kristin Newby, Eric D. Peterson, Judith S. Hochman

    Resumen Resumen Esquema Esquema  

• Letter to the Editor

  • ·Are we sure we have taken the best from clopidogrel?

    Página :e59

    Bernardo Cortese, Andrea Picchi, Andrea Micheli, Ugo Limbruno